3rd Quarter - Report
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Promoted life sciences community and communicated economic and health benefits of the industry. H.R.1628: American Health Care Act and S. Better Care Reconciliation Act. H.R.2430/S.934: FDA Reauthorization Act of 2017. Education about the value of innovative new medicines. H.R.849/H.J.Res 51: IPAB Repeal Act and Joint Resolution related to IPAB Repeal.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
H.R. 184: Protect Medical Innovation Act. H.R.1645: Fostering Innovation Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.